AeroLeads people directory · profile

Ed Piper Email & Phone Number

VP, Medical and Scientific Affairs Director, AstraZeneca UK at AstraZeneca
Location: London, England, United Kingdom 10 work roles 4 schools
1 work email found @astrazeneca.com LinkedIn matched
✓ Verified August 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email e****@astrazeneca.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
AstraZeneca
Role
VP, Medical and Scientific Affairs Director, AstraZeneca UK
Location
London, England, United Kingdom
Company size
78605 employees

Who is Ed Piper? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Ed Piper is listed as VP, Medical and Scientific Affairs Director, AstraZeneca UK at AstraZeneca, a with 78605 employees, based in London, England, United Kingdom. AeroLeads shows a work email signal at astrazeneca.com and a matched LinkedIn profile for Ed Piper.

Ed Piper previously worked as VP, Medical & Scientific Affairs Director, AstraZeneca UK at Astrazeneca and VP, Global Franchise Head, AZ Core Inhaled Respiratory Products at Astrazeneca. Ed Piper holds Mbbs, Medicine from United Medical And Dental Schools Of Guys And St Thomas'.

Company email context

Email format at AstraZeneca

This section adds company-level context without repeating Ed Piper's masked contact details.

epiper@astrazeneca.com
79% confidence

AeroLeads found 1 current-domain work email signal for Ed Piper. Compare company email patterns before reaching out.

View email format View company profile Management contacts
Profile bio

About Ed Piper

>20 years as pharmaceutical industry physician. Experienced medical leader with global clinical development, medical affairs, regulatory, commercial strategy & business development experience. Cross-functional R&D project leadership know-how with accountability for life-cycle management of major in-market brands.Therapy area experience in Respiratory (asthma, COPD, idiopathic pulmonary fibrosis) Dermatology (atopic dermatitis), Diabetes, Obesity, Cardiovascular (lipids, hypertension, ischaemic heart disease). Biologics and small molecules.Skills drawn from hands on product development across all phases of development - first time in human, proof of concept, phase 3 and real world studies. Deep regulatory experience including face to face interactions at FDA, EMA, MHRA and PMDA, product submissions and approvals.Expert in external relationship management with investors and key opinion leaders.GMC registered. Qualifications: BSc, MBBS, MRCGP, MFPM, DCH, DRCOG

Listed skills include Clinical Development, Hypertension, Clinical Research, Cardiology, and 7 others.

Current workplace

Ed Piper's current company

Company context helps verify the profile and gives searchers a useful next step.

AstraZeneca
Astrazeneca
VP, Medical and Scientific Affairs Director, AstraZeneca UK
London, GB
Website
astrazeneca.com
Employees
78605
AeroLeads page
Company profile
View company profile Email format
10 roles · 26 years

Ed Piper work experience

A career timeline built from the work history available for this profile.

Vp, Medical And Scientific Affairs Director, Astrazeneca Uk

Astrazeneca

London, Gb

Vp, Medical & Scientific Affairs Director, Astrazeneca Uk

Current
Astrazeneca

Cambridge, Cambridgeshire, Gb

Accountable for AstraZeneca UK medical strategy across Cardio-renal, Respiratory, Immunology and Vaccines therapy areas. Drives to establish UK as a leading launch market with earliest possible Regulatory and Payer access to bring our medicines to healthcare professional and patients. Prioritises delivery of practice-changing real world evidence to differentiate brands and provide evidence base for clinical guidelines. Establishes innovative partnerships seeking to re-wire clinical pathways, improve clinical outcomes and reduce geographical variations in care. Leads a team of ~100 employees across Medical Affairs, Field Medical, Evidence, Regulatory, Patient Safety & Medical Information.

Jan 2022 - Present

Vp, Global Franchise Head, Az Core Inhaled Respiratory Products

Astrazeneca

Cambridge, Cambridgeshire, Gb

Accountable for R&D for AZ inhaled franchise including in-market Respiratory products Symbicort, Pulmicort, Duaklir, Daxas and PT027 (budesonide/albuterol) in Phase 3 development. Delivered >40 world-wide approvals for a new asthma indication for Symbicort. Working with clinical development partner Avillion, delivered three positive phase 3 trials leading to US NDA submission for PT027 (NDA under-review through 2022). Supported divestment of aclidinium franchise to Covis Pharma. Led three, cross-functional Global Product Teams with members across UK, Sweden, Spain and US.

May 2019 - Jan 2022

Vp, Early Respiratory Portfolio

Astrazeneca

Cambridge, Cambridgeshire, Gb

Led AZ Global Portfolio and Product Strategy team responsible for the commercial strategy for all AZ/MedImmune pre-phase 3 Respiratory assets in asthma, COPD, chronic cough, idiopathic pulmonary fibrosis. Responsible for search and evaluation of Respiratory business development opportunities including assessment of in- and out-licensing opportunities.

Sep 2017 - Mar 2019

Vp, Global Medicine Leader

Astrazeneca

Cambridge, Cambridgeshire, Gb

Leader of tralokinumab cross-functional Global Product Team for EU, US and Japan development. Included phase 3 severe asthma programme and phase 2 lifecycle management studies in IPF and atopic dermatitis. Tralokinumab is an anti IL-13 mAb.

Apr 2015 - Sep 2017

Clinical Therapy Area Head For Cardiovascular Metabolic Disease

Medimmune

Gaithersburg, Maryland, Us

Responsible for the clinical development of a portfolio of biologic assets in the cardiometabolic therapy area (obesity, diabetes, CKD, lipid modulation) managing a US/UK team with expertise in both strategic clinical development and study execution.

Sep 2013 - Mar 2015

Senior Director & Interim Head Of Respiratory Clinical Development,

Medimmune

Gaithersburg, Maryland, Us

I led a team of 9 Clinical Development MDs and Scientists located in US and UK focused on delivery of MedImmune Respiratory Biologics Portfolio targeting asthma, COPD & IPF. Global clinical development lead for tralokinumab (anti IL-13 mAb)

Jan 2009 - Sep 2013

Senior Medical Director (Cardiovascular R&D)

Takeda Pharmaceuticals

Tokyo, Jp

I led the cross functional team responsible for US and European development of a lipid lowering compound (lapaquistat) through Phase III development. I also worked on 2 ARBs (Phase III and IV) and a factor Xa inhibitor.

Apr 2005 - Jan 2009

Medical Affairs Manager

Aventis Pharma Uk

I led the medical affairs team for diabetes compounds. In this role I provided the medical support for the launch of Lantus (Insulin glargine) in UK and late stage development of Exubera (inhaled insulin) together with Pfizer. During my time at Aventis I also worked on osteoporosis (Actonel) and rheumatoid arthritis (Arava) compounds.

2001 - 2005 ~4 yrs

Principal In General Practice

Amherst Medical Practice
Jan 2001 - Dec 2001
Team & coworkers

Colleagues at AstraZeneca

Other employees you can reach at astrazeneca.com. View company contacts for 78605 employees →

HE Hilal Erol, Md Hilal Erol, Md Colleague at AstrazenecaGreater Izmir, Turkey View → RF Rofik Firmansyah Rofik Firmansyah Colleague at AstrazenecaBandung, West Java, Indonesia View → SB Sneha Balu Sneha Balu Colleague at AstrazenecaChennai, Tamil Nadu, India View → SH S. Hassan N. S. Hassan N. Colleague at AstrazenecaBaltimore, Maryland, United States View → TT Teresa Tormo Sanchis Teresa Tormo Sanchis Colleague at AstrazenecaValencia, Valencian Community, Spain View → CM Carolina Meyn Teixeira Carolina Meyn Teixeira Colleague at AstrazenecaGreater São Paulo Area, Brazil View → AH Ashok Hc Ashok Hc Colleague at AstrazenecaBengaluru, Karnataka, India View → KM Kaley Moore Kaley Moore Colleague at AstrazenecaMorristown, Tennessee, United States View → OA Oscar Aviles Oscar Aviles Colleague at AstrazenecaGuadalajara, Jalisco, Mexico View → SK Sarah Kamel Sarah Kamel Colleague at AstrazenecaGiza, Al Jizah, Egypt View →
4 education records

Ed Piper education

Mbbs, Medicine

United Medical And Dental Schools Of Guys And St Thomas'

Education record

Tonbridge School

Education record

Tonbridge School, Tonbridge, Kent, Uk

Education record

Homefield School
FAQ

Frequently asked questions about Ed Piper

Quick answers generated from the profile data available on this page.

What company does Ed Piper work for?

Ed Piper works for AstraZeneca.

What is Ed Piper's role at AstraZeneca?

Ed Piper is listed as VP, Medical and Scientific Affairs Director, AstraZeneca UK at AstraZeneca.

What is Ed Piper's email address?

AeroLeads has found 1 work email signal at @astrazeneca.com for Ed Piper at AstraZeneca.

Where is Ed Piper based?

Ed Piper is based in London, England, United Kingdom while working with AstraZeneca.

What companies has Ed Piper worked for?

Ed Piper has worked for Astrazeneca, Medimmune, Takeda Pharmaceuticals, Aventis Pharma Uk, and Amherst Medical Practice.

Who are Ed Piper's colleagues at AstraZeneca?

Ed Piper's colleagues at AstraZeneca include Hilal Erol, Md, Rofik Firmansyah, Sneha Balu, S. Hassan N., and Teresa Tormo Sanchis.

How can I contact Ed Piper?

You can use AeroLeads to view verified contact signals for Ed Piper at AstraZeneca, including work email, phone, and LinkedIn data when available.

What schools did Ed Piper attend?

Ed Piper holds Mbbs, Medicine from United Medical And Dental Schools Of Guys And St Thomas'.

What skills is Ed Piper known for?

Ed Piper is listed with skills including Clinical Development, Hypertension, Clinical Research, Cardiology, Copd, Clinical Pharmacology, Internal Medicine, and Asthma.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.